Skip to main content
Smart Investors Daily
IN

OTC · INBP

Integrated BioPharma, Inc.

Consumer Defensive · Packaged Foods

$0.19

Up+$0.00 (+2.16%)

Updated Oct 7, 2026, 9:15 PM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
9.58M
P/E ratio
14.26
Dividend yield
0.00%
52-week range
$0.14 – $0.42
Volume
705
Avg. volume
12.92K

Price performance · INBP

INBP price history

1M range · 0 trading sessions · Daily adjusted prices

INBP does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest INBP news

The latest Smart Investors Daily articles mentioning INBP.

INBP research

Overview

Company profile and research snapshot.

Company profile

INTEGRATED BIOPHARMA INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

globenewswire.com · Dec 2, 2025

Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions

LAUPHEIM, Germany and MARTINSRIED, Germany and MUNICH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Coriolis Pharma, a globally operating contract research and development organization (CRDO) and a leader in formulation research and development for biopharmaceuticals, today announced a strategic collaboration.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.